Journal
AMERICAN JOURNAL OF EMERGENCY MEDICINE
Volume 46, Issue -, Pages 16-19Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ajem.2021.02.054
Keywords
COVID-19; Coronavirus; Absolute lymphocyte count; Lymphopenia
Categories
Ask authors/readers for more resources
In this study, the sensitivity of absolute lymphocyte count in patients with COVID-19 who required subsequent hospitalization was explored. Cut-off values ranged from 1.1 K/uL to 2.0 K/uL, with sensitivities of 72% and 94% respectively. Additionally, lower mean absolute lymphocyte counts were identified in males, patients requiring intubation, and patients who died.
Introduction: Symptoms of COVID-19 vary in severity and presentation. When admitting patients to the hospital, it is desirable to isolate patients with COVID-19 from those without the disease. However, reliably identifying patients with COVID-19 in the emergency department before hospital admission is often limited by the speed and availability of testing. Previous studies determined a low lymphocyte count is commonly found in patients with COVID-19. We sought to explore the sensitivity of absolute lymphocyte count in patients presenting to the emergency department requiring subsequent hospitalization who were found to have COVID-19. Methods: A retrospective chart review was performed on 312 patients with laboratory-confirmed COVID-19 who were admitted to the hospital from the emergency department. The absolute lymphocyte count for these patients was used to calculate sensitivities at various cut-off values. The relationships between absolute lymphocyte count and variables, including age, sex, need for intubation, and mortality, were also explored. Results: Cut-off values for absolute lymphocyte count ranged from 1.1 K/uL to 2.0 K/uL, with sensitivities of 72% and 94%, respectively. Additionally, lower mean absolute lymphocyte counts were identified in males, patients who required intubation, and patients who died. Conclusion: Knowing the sensitivity of absolute lymphocyte count in patients with COVID-19 may help identify patients who are unlikely to have the disease. Additionally, absolute lymphocyte count can be used as a marker of disease severity in patients with COVID-19. (c) 2021 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available